CENTRAL RETINAL VEIN OCCLUSION IN A YOUNG ADULT DURING RISPERIDONE THERAPY
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 2 (3) , 199-201
- https://doi.org/10.1097/icb.0b013e3180601196
Abstract
Background: Various articles in the literature point out the higher risk of venous thrombosis in patients taking antipsychotic drugs. However, to our knowledge, an association with central retinal vein occlusion (CRVO) has not been reported before. Methods: We describe the clinical and angiographic findings of a patient with CRVO that may have been related to his antipsychotic medication. Results: A 19-year-old patient had been taking risperidone and fluoxetine for the last 7 months. He presented with atypical nonischemic CRVO with atypical deep intraretinal hemorrhages, a swollen optic disk, dilatation and engorgement of retinal veins, and optic disk capillaries. Despite a detailed workup, no systemic or ocular risk factors for a thromboembolic event were found. He had hyperprolactinemia resulting from his medication. Conclusion: The use of risperidone may be a risk factor for CRVO.Keywords
This publication has 4 references indexed in Scilit:
- Hyperprolactinemia in Patients on Antipsychotic Drugs Causes ADP-Stimulated Platelet Activation That Might Explain the Increased Risk for Venous Thromboembolism: Pilot StudyJournal of Clinical Psychopharmacology, 2003
- Inhibition of Risperidone Metabolism by Fluoxetine in Patients With Schizophrenia: A Clinically Relevant Pharmacokinetic Drug InteractionJournal of Clinical Psychopharmacology, 2002
- Antipsychotic-Induced Venous ThromboembolismCNS Drugs, 2002
- Systemic diseases associated with various types of retinal vein occlusionAmerican Journal of Ophthalmology, 2001